Recently, TNF and JAK inhibitors, previously proven to treat many dermatological and autoimmune diseases, were applied to CA patients to evaluate the promise and perils of these classes of drugs [9, 10, 14, 18]. This evidence concerns the gene TNF and autoimmune disease.